Apple’s Rally Keeps Running… And Trump’s Crypto Plans 12/12/24

12 Dec 2024 · 44 min

Ask about this episode

Ask anything about it. ChatGPT or Claude reads this page and answers with the times it was said.

Connect VO and ask about every podcast you hear, including the moments you saved. Add to ChatGPT · Add to Claude

In short

Podcast Summary: CNBC's "Fast Money" - Apple’s Rally Keeps Running… And Trump’s Crypto Plans (12/12/24)

Episode Overview In this episode, hosted by Melissa Lee, the panel of top traders discusses Apple's continuing stock rally, the implications of President-Elect Donald Trump's statements on cryptocurrency, and a variety of market factors influencing both tech stocks and digital currencies.

Key Topics

  1. Apple's Stock Performance
  2. Apple shares have reached record highs, closing in on a market cap of $4 trillion.
  3. Despite disappointing iPhone sales and AI product critiques, the stock has surged by over 10% in the last month and 51% since its lows in April.
  4. Analysts began questioning the sustainability of this rally, noting fundamental weaknesses in Apple's business model, especially with over-reliance on iPhone sales.
  5. The discussion highlighted Apple's defensive positioning in the current market despite its challenges.
  1. Market Dynamics
  2. The panel discussed the concept of momentum investing, with Apple benefiting from being a major holding in various ETFs, leading to significant money flow into the stock.
  3. A sentiment emerged that the current rally may not be driven by strong fundamentals, raising concerns over future valuation and growth.
  1. Trump's Stance on Cryptocurrency
  2. The episode shifted focus to Donald Trump's vision of making the U.S. a leader in cryptocurrency.
  3. Bitcoin is hovering near $100,000, and experts predict that clarity in regulations could drive further institutional investment into the crypto space.
  4. The discussion included the potential impact of Trump’s administration on the crypto market, emphasizing the importance of regulatory clarity for institutional investors.
  1. Corporate Earnings Updates
  2. The panel reviewed earnings from companies such as Costco and RH (Restoration Hardware), highlighting their performance amid market fluctuations.
  3. Costco reported strong comparable sales growth while RH saw considerable stock movement following a guidance increase.
  1. Service Titan's IPO
  2. The episode also covered the debut of Service Titan, which opened above its IPO price, reflecting investor interest in tech-enabled service companies.
  3. The factors leading to its IPO pricing and investor sentiment towards tech IPOs were discussed.
  1. Economic Indicators
  2. The impact of rising yields and inflation data on the market was analyzed, with traders speculating on the Federal Reserve's future policy direction.
  3. There was a strong focus on the health of the labor market and its implications for economic growth.
  1. General Market Sentiments and Predictions
  2. Experts expressed varying views on market direction, with some highlighting the potential for growth in smaller companies post-election.
  3. The panel identified sectors, particularly healthcare and smaller-cap stocks, as areas to watch for potential investment opportunities.

Key Takeaways

  • Apple's Valuation Concerns: Despite its stock performance, fundamental issues (such as reliance on iPhone sales) could challenge Apple's long-term growth.
  • Crypto Market Potential: Institutional interest in crypto may grow as regulations clarify, indicating a bullish outlook for Bitcoin and other digital currencies.
  • Economic Outlook: Rising inflation and jobless claims raise questions about future Fed actions, with implications for tech and growth stocks.
  • Market Leadership: There is growing interest in diversifying investments outside of tech giants, with potential opportunities in healthcare and small to mid-cap firms.

Conclusion This episode of "Fast Money" provides a multifaceted view of the current financial landscape, focusing on significant players like Apple and emerging trends in the cryptocurrency space. The discussions around market dynamics, corporate earnings, and economic indicators offer valuable insights for investors navigating the complexities of the market.

Written by AI. May contain mistakes. Listen to the episode to check what was said.

Hear the part that matters, and keep it.Open this episode in VO. Double tap your headphones to save a moment as you listen.
Get VO free

Transcript

Automatic transcript. May contain errors.

0:02Live from the Nasdaq market site in the heart of New York City's Times Square. This is Fast Here's what's on top tonight. Unstoppable Apple shares just keep going up despite lackluster iPhone sales, less than seller reviews for its AI offering and continuing concerns about China. What is behind this record run and what does it say about the market we are in? Plus, Trump's crypto boasts the president-elect telling Kramer this morning he wants the U.S. to be the leader in the digital currency space. How his administration's embrace will impact Bitcoin and beyond. And later, breaking down service, Titan's big first day as a public company, digging in the details of Costco's earnings and giddy up by horse racing could be ready to rebound after decades on the decline.

0:42I'm Melissa Lee coming to you live from Studio B at the NASDAQ on the desk tonight. Karen Feinerman, Dan Nathan and Guy Adami. Sis? Yeah, yeah. Yeah, pressure's on. We start off with the latest record close for Apple. Shares of the iPhone maker now up more than 10 percent in just the last month and a whopping 51 percent from April lows. The stock closing today with a market cap just a stone's throw away from$4 trillion. That is more than the entire GDP of the United Kingdom. This year's rally coming even as the tech giant's efforts in the AI space fail to impress users poking fun at Apple intelligence's awkward chat summaries, faulty image editing, and sometimes bizarre Genmoji capabilities like making poop hair on a face.

1:24Yes, yes. Dan will tell you all about it. Apple also saw iPhone sales in China fall for the third quarter and is struggling in its partnership with Baidu to bring AI to its devices there. So with this rally going strong in spite of these concerns, has Apple become the ultimate defensive play? Does this just tell us the tale of the market where momentum is the word of the day, Guy? I think you hit the nail on the head. And, you know, you try to figure out why this is happening. I don't think it's happening for any fundamental reasons. Obviously, the market's been doing fine. So you try to figure out what's going on below the surface.

1:55There's a couple things, I think. Semis have actually now underperformed since July-ish, if you look at the chart. Qualcomm, Micron, Texan, names that we talk about all the time, really actually have traded poorly. AMD throw it in the mix. So I think in some ways there's been a rotation out of semis. And the other is Apple's in 400 ETFs, of which it's one of the top 15 holdings. So as money flow goes, Apple wins regardless of what they're saying. It's just a money flow thing as well. So I get it. But with each passing day, it's getting more expensive, not cheaper. Yeah. And, you know, it's interesting.

2:29So we used to talk about the cash. We used to talk about their buyback. We used to talk about their dividend. They're like rounding errors right now. If you look at their cash position, it's like four percent of the market cap net of their debt. It's like minuscule. Right. And then their buybacks. You know, remember that day earlier this year, they announced one hundred and ten billion dollar buyback. And actually the stock rallied. And, you know, think about that. It actually has no impact anymore. So you look at a stock right there. That whole part was really from 2012 when they announced that buyback till, I want to say, about five years ago.

2:58That was a really important part of the story. You started off saying defensive. But here's the problem. Fifty percent of their sales now come from iPhones. They're not growing. And this services thing, the AI, you know, this is the next leg of growth. This is the thing that would justify the multiple where it's trading at. It's just there's no there there. So I've never been so right about one thing and so wrong about the other. The right thing was June 10th when they had their WWDC. It looked very obvious to me what was going on there. It was a fugazi. And everything since then has been a joke, except the stock has rallied 30 percent since June 10th.

3:32That's the wrong part right there. So, I mean, sometimes it just both things can be true. Both things can be true. I think, you know, the buyback thing, what used to be super accretive when they traded a very different multiple, is actually not accretive now. But it's interesting. I mean, I own a little, and I've been sort of surprised with how strong it is. I don't really get this. I was only up a little bit today, but this valuation here, it's not super crazy. But if you, you know, we always talk about looking at the hardware and the software part, which we know the multiple, the contribution of each is changing towards services, which is much more profitable and recurring.

4:13But you'd think that China issues would really affect them a lot. On the other hand, though, Tim Cook has been very adept at, you know. Cozying up to Xi Jinping. Yes, yes, yes. That would be one way to say it. And, yeah, I think that would be right. And it's worked for him. But I think, I don't know, it's just sort of in the melt-up. There are other things I like much better, like a meta, you know, just valuation-wise. I'd much rather be there. That's what's interesting is that, you know, with the meta story, it really sort of underscores this notion that AI can, the effects can be seen. Right.

4:46In real. Like we can actually see them right now. The impact on its business, the impact on what it sells, its ads, et cetera. And yet with Apple, we don't have that impact. And yet it did levitate from that June date of the WWDC on the AI hopes. And here we are. What are they? It's Genmojis. It's summarizing notes. It's image generation. Gene Munster comes on and talks about that and the hope. And listen, Gene's going to wind up being right. By the way, he came on on that same day, June 10th, and said it was, I don't want to put words in his mouth, but transformational, one of the biggest events in the history of the company.

5:20So good for Gene in terms of the stock. He got it right. But you're right. I mean, in terms of AI, and we've talked about it on this show, there are two companies that are clearly winning in the AI world in terms of making and monetizing. And it's Walmart. And you see it in earnings releases the last two times. And it's Facebook over their last two earnings releases. And they're being rewarded for it in terms of the stock price and the valuation. Apple's being rewarded for something they're not monetizing yet. and quite frankly might have trouble doing over the next year, year and a half. So you guys may find this interesting, but I'm going to try to pick apart some of these big names that have supposedly accrued a lot of the value, at least in some of the investments that they've made in generative AI over the last year.

5:57Let's leave NVIDIA out of it because we all know that that is deserved, whether you think the percentage gains or not. But let's look at Meta that you guys just mentioned. They are totally reliant on iOS devices for people to use them, for the most part, here in America. They will not be in China, okay, because they don't make it past the firewall. You could say that those are headwinds. Amazon, they don't own, they're building a model, right, for all intents and purposes, but they have a very competitive landscape as it relates to their hyperscale, their AWS business, okay? They are leasing basically for all intents and purposes, Anthropics, you know, model and that sort of thing.

6:34Microsoft, it looks like this is kind of a dud, this licensing of open AI. They haven't been able to do a great job integrating it. Co-pilot is a big, you know, meh, as you guys say. And then they're just not getting a lot of uptake of the co-pilot as it relates to enterprise. So, I mean, there's things to kind of pick at. I'm probably missing. Oh, Google. You know, Google, this has been a bit of a train wreck, Gemini, and integrating it. I think it's better than Apple intelligence. But, again, I think there's things to pick at in a different sort of environment. You know, like I'm not sure that these are the ones that get going in 2025.

7:04The story has to broaden out a little bit. Why is not being in China Hedwin from Meta? Yes. Yes. Well, there's how many people? You know how many billion people there are. Right, but that's been the way it is. It's not like you're here. Why are you looking at it? I know, too. She's been there a few times. You know what I mean? Like, I've been there a couple times. There's a lot of people there. I'm just saying. But they're doing just fine. Can I tell you why? Okay. Go ahead. Because they have three billion people. You take a billion and a half out of China, and that's not. Wait, wait, wait. It's as if that.

7:28But they were never in China. It's not as if this is a market that they were losing. There's nothing in the valuation for China. There's nothing priced in, which is the right price. I understand. But what I'm saying is at some point, they're only going to be able to get so many more people on the planet to kind of use their services. That's a pretty good market that you'd want to be in. I think they're looking to monetize the services more broadly, not necessarily. I mean, the more people you have, the better. But having them spend more, which is what has happened. I mean, Meta is 100 % the best story right now, in my opinion, for a whole host of reasons.

7:55And you talk about valuation, but they are squarely. I have the Meta Wayfarer. These glasses, have you guys seen these things? Yes, I have. They're amazing. You're admitting to it? Zuckerberg gave Donald Trump a preview at Mar-a-Lago. Yeah. And then he gave him the Ray-Ban. These things are amazing. I mean. What? Last word here. No, they're no last words. The last word. There are too many words. You see these people. Dan's one of them walking around with these glasses on, talking to themselves, and then hitting the little button on the side to take a picture of you while they're talking to you.

8:28It's confusing to you, right? That's creepy as you know what. I love it. All right. Meantime, 10-year yields hitting their highest level since before Thanksgiving on the back of a hot inflation report and a jump in jobless claims. Producer prices rising four-tenths of a percent in November, twice as much as expected. That combined with more people filing for unemployment benefits raised fears over economic growth ahead of next week's Fed meeting. Karen, you said before that you were surprised the 10-year didn't move more on this. Yes, I would have thought. I mean, we've got PPI, so that's inflation.

8:58But then we have the potential for tremendous growth and, you know, more deficits and all of that. I mean, that's also why I get to the idea that the Fed will not be cutting dramatically in 2025. I don't know why they need to, especially if the economy is going. Karen's done a great job with this, by the way. And, you know, I'm still one of the very few people, I think, that the TLT is going back to levels we saw this time. well, October of last year, which is about 82.5%, which gets you to about somewhere between 485 % and 5 % in the 10-year. I know it sounds preposterous, but, you know, I just think yields are going higher for a myriad of different reasons.

9:35There are people a lot smarter than I am that are betting on the same. Paul Tudor, Jones, Stan Druckenmiller, for example. And, you know, it just makes sense with all the issuances that are coming forth in the first quarter of next year. Something's got to give. They're not going to be failed auctions, but the market's going to demand a higher rate of interest to buy our debt. And you guys are saying this. Rates are going lower. Yields are staying put. The dollar looks like it wants to break out about a range that it's been in for like a couple years or so. So all of these things, you know, you guys were challenging my headwinds to the tech story.

10:04These seem like headwinds to the economy going forward. Just a meta. Yeah, just a meta. Also a little meh auction, as you would call it. For the 30 years. Yes, for the 30 years. All right. For more on rates and where we can go from here, we are joined now by Stephen Whiting, City Wealth's chief investment officer and chief economist. The firm just unveiled its 2025 investment outlook. Alexieman, good to see you. Oh, thanks for having me. So you're looking for growth in 2025 and 2026. But even with that backdrop, you think investors are too concentrated in their portfolios? Well, look, I mean, step back.

10:32This isn't fast money stuff. But when you think about three American companies are worth all of the companies in Asia or all of the companies in Europe, it isn't even a PE issue. I mean, we have rapid growth in our tech companies. That's great. Multiples are going from 50 down to 30 because of all that growth. But there's been a lot of good fortune here. I mean, just think about large cap U.S. stocks have had a 13 percent return for a decade, right? So what we see is just the opportunity elsewhere. Small and mid cap American companies, growth companies have had a decline in valuation in the last 10 years.

11:07Compared to where we were when Donald Trump was first elected, in U.S. dollar terms, non-U.S. assets are 40 percent cheaper in forward looking valuations. It doesn't mean that they're going to come alive and just jump really, really sharply. We went into this election, 6 percent overweight U.S. equities. We've got to start thinking about more diversification, some opportunity and cheaper assets for the next 10 years. How do you think about this run that we have seen since the election? I mean, is this sort of policy hopes and dreams pull forward? It's a lot like when Donald Trump was first elected.

11:43We saw the dollar rise through the end of the year quite discreetly. There probably is less room for significant fiscal easing. There's a smaller majority in the House. We have tax hikes coming unless we do otherwise. I think there's legitimate hope for deregulation. Energy and power infrastructure, financials, banks, a lot of headwinds can disappear. But a lot of this gets priced discreetly just over a period of time. And then we move on to other more lasting sources of growth. So let me ask you something, and I'm playing devil's advocate a little because I'm long IWM, but what about this phenomenon that has nothing to do with valuation, but has everything to do about flow of funds into the market, into bigger, more liquid?

12:27Do you see that changing at all? So I think EPS itself, again, turning on a breadth of profits that's better. 2025 estimates for small and mid-cap look a lot better if they can actually execute on it, I think you'll see performance follow those gains in EPS. So far, we've had a really narrow economy, especially looking back in the last 12 months. You know, there were a lot of gains for AI infrastructure. But if we look at 12 months ago, half of industries had EPS declines, so quite narrow market. I think, again, we can get back from that. And corporate profits generally haven't looked as good as the labor market in the last one, two years.

13:08Love this one. Number two on the 2025 top six is medical devices, which has been out of favor now for a while, probably in the back of GLP, a number of different things. Speak to that, because I actually really like that. Nine percent historic dividend growth, 14 P multiples. Again, it's probably important for stock picking in terms of actual dispersion. But if you think about the two industries of what the economy is becoming, technology and health care is what the economy is becoming. We have a lot of confidence in future profits priced into tech, very little confidence priced into health care.

13:42And so basically health care is quite cheap. It looks a lot like, you know, the tech recovery from 2022. All right. Stephen, thanks for stopping by. Great to see you. My pleasure. Medical devices, that is interesting, especially when you think about the medical loss ratios of the insurers are so high because utilization rates are so high. You've got to think, you know, those devices are going in somewhere. Yeah, and its evaluation plays so spot on. I mean, Medtronic is a name that comes to mind right off the top of the – I mean, just valuation alone, this becomes compelling. And these stocks have just been beaten up on what's been a great tape for a number of different reasons, some of which are justified, some not so much.

14:18So I love that call in 2025. Yeah, it's interesting. XLV, if we can pull a chart up, maybe a five-year. For 2021, 2022, 2023, it was really in a tight range. It broke out earlier this year. It looked like one of the best-looking charts, one of the best stories. And now it's down a whole heck of a lot from those highs. and it looks horrible. And so when you think about how does the market broaden out, where does some new leadership come from? We know a lot of these sectors don't make up enough on their own, you know what I mean, to kind of power gains. But I think that's the story. How can you put a couple narratives together and how can this leadership broaden out if the Gen.A.I.

14:49trade was to take a little bit of a breather? But how do you think about Elevance, for instance, at this point? Well, can I just address XLV for a second, which is the H in my helm trade, XLV. Play that game correctly. You played that game correctly. Health care. Health care. So she gets a pass on that. XLV, health care. Great game, by the way, that we play every year. To your Elevance question, I mean, I think, and maybe to XLV more broadly, for each and for both potential administrations and now Trump administrations, here is a great target, right, bipartisan support, until you get the lobbying coming in, which happens later, but bipartisan support for, you know, caps on prices or some sort of pricing mechanism that isn't as good.

15:34And certainly for Elevance, which does have Carillon, which is their PBM, pharmacy benefits, that's been weighing on it as well as a couple of other things. I haven't done a good job with this one. But you still have it. Yes. Yes, right. By definition. We've got an earnings alert here on Broadcom. The chipmaker right now is higher by about 4 % in the after hours after its fourth quarter results. the chipmaker missing revenue expectations, beating earnings per share. The conference call just kicked off. Seema Modi's got the number. Seema. Melissa, Broadcom's bet on artificial intelligence seems to be paying off with 2024 AI revenue growing 220 % year over year.

16:15CEO Hock Tan on the call just now saying that he sees the momentum continuing, touting its AI revenue growth, which was driven by XPU accelerators and networking. On the non-AI business side, broadband, he thinks, will bottom and the recovery will start in the first quarter. It also closed its$69 billion acquisition of VMware and integration is complete, he says, with a number of new enterprise clients. The company is raising its dividend by 11 percent. And we've been watching shares of Broadcom outperform the chip sector this year, stock up over 69 % as it partners with the likes of OpenAI, Amazon, Meta to help each of them build their own customized AI chip.

16:54All, by the way, fab with Taiwan Semi. We'll look for more details on the timeline and confirmation on whether it is working with Apple to design its own AI chip. Right now, Melissa, shares of Broadcom up over 4 % in After Hours. All right, Seema, thank you. Seema Modi. And of course, there's also the headline today that Apple is working to replace Broadcom when it comes to, you know, having its own in-house chip for Wi-Fi as well as Bluetooth. So ending the relationship in some instances, building up a new one potentially in others. Yeah, you know, that might actually not be a bad thing for Broadcom, quite frankly, but that's another conversation.

17:27I mean, you look at the quarter, 62.7 % operating margins for this company. Slight miss on, I mean, really slight miss on revenue, beat on EPS. And the first times next year's numbers-ish. I mean, I think this stock is still going higher. You get through 186, a level we've had trouble with, and I think you're in a whole new range on the upside. Yeah, I think your point about the Wi-Fi and the Bluetooth chips, I mean, that's something that, again, you know, they're going to design generative AI chips, so maybe that does offset it. You know, Apple is a huge customer, 70 to 17 percent of Broadcom, and, you know, this thing is acting very contrary to many of the other names attached to what we saw.

18:04Marvel Tech telling a story about generative AI last week, it had a huge rally. It gapped up 25 % on those earnings due to new all-time highs. Coming up, more after hours action, this time on retailers, Costco and RH. Those names on the move after reporting results and numbers from the quarter next. And a big debut for Service Titan, the cloud software provider surging in its NASDAQ debut. Why investors are so hot on this tech name? Straight ahead, don't go anywhere. Fast Money's back in two.

18:36Welcome back to Fast Money. Earnings alert on Costco. Shares are a little bit lower in the after-hour session after reporting a top and a bottom line beat. The conference call began at the top of the hour. Melissa Repko joins us with all the details. Melissa. Yes, so Costco shares are barely moving despite the company beating on the top and bottom line. The Warehouse Club said comparable sales rose 5.2 percent in the quarter and e-commerce shot up by 13 percent year over year. Membership fees also came in on the high side, higher than Wall Street expected, totaling$1.17 billion compared to the$1.16 billion that analysts expected.

19:09The Warehouse Club had hiked its annual fee in early September, the first increase in about seven years. But Gary Millerchip, the CFO on the company's earnings call, said that that actually did not have an effect on the quarter. He said it didn't have much of an impact yet because of deferred accounting and represented less than 1 % of that fee growth in the quarter. On the company's earnings call, he also called out a few areas of growth. Gold and jewelry, gift cards, home furnishings, sports goods, health and beauty aids, and luggage were all up double digits. So some sense of what people are buying this holiday season potentially.

19:44Back to you. That's a lot of categories with demand. Melissa, thank you. Melissa Repko. Remember when they were selling also platinum, gold, silver, and they're selling out. People buying the luggage to put the gold bars in to get them out. Exactly. You think I'm kidding around. Except that the gold is like this big. I know. I'm kidding. It's heavy, though. A little troy ounce. That's true. Yeah. But we were talking about Costco. Costco, of course, all-time high yesterday. So really performing. The valuation could be perceived as rich, but they are executing. I mean, in isolation, in a vacuum, that is a fantastic quarter versus other retailers, right?

20:19Up 5.2%. I mean, but to your point, 55 plus times. Right. That's not good enough. I mean, Walmart's at 35. Yeah. And Target's at 14. I mean, clearly, they're different animals completely. But so this makes me feel a little bit good that I don't own it, that it's down like$2 or$3. Like a quarter of a percent? Yeah, right. Go Karen. You know, you take the wins where you can get them. Yeah. I mean, you say what you want, though. I mean, razor thin margins. So when they beat by the margins that they did. So, for example, operating margins was 3.53 percent. Doesn't sound like a big deal. For them, it's a big deal.

20:58Street was looking for less than 3.3. So they're operating better. And maybe in the world of AI, they'll operate even better. Better. Better. So I get the valuation concerns. concerns, but as Karen will tell you, I mean, there have been valuation concerns for the last five years the entire way up about Costco. More after hours action here. Shares of RH soaring on a big guidance raise. The company now seeing revenue growth between 18 and 20 percent in the fourth quarter compared to a 7 percent estimate. Earnings for this quarter did fall short of expectations, though, while revenues were in line with estimates.

21:33It's a big pop here. You ask, was there short interest here? 12 percent of shares outstanding. Yeah, a little bit, but this was pretty good, though. I think they also talked about strength. Was it November? Good strength there. So that gives them the guidance. I think imagine what will happen when people buy new homes again in a much right when existing homes come out of, you know, the cheap mortgage rate block. But this is pretty impressive. However, that having been said, still, I think, too expensive. Yeah. They also said on the conference call, apparently, that their margins would not be impacted by tariffs, which is a big deal.

22:10Yeah, that was important. Yeah. This was again, not that it matters. This was a seven hundred dollar stock in twenty twenty one that just absolutely cratered like a lot of other things. So the move now basically gets us to a 50 percent retracement of that prior high and the lows we've been trading at for the last, I don't know, year and a half or so, two years. It's going to trade north of 10 million shares tomorrow. I think you've got to let it breathe. I think it'll sift back in for you. All right. There's a lot more Fast Money to come. Here's what's coming up next. The newest kid on the block, Service Titan, making a splash in its IPO.

22:42The details from its first trading day and why the company priced well below its range. Plus, Bitcoin hovering near 100K. And our next guest says the rally is just beginning, where he sees crypto prices heading and what President-elect Trump is saying about the space. You're watching Fast Money live from the NASDAQ market site in Times Square. We're back right after this.

Read the full transcript

23:17Welcome back to Fast Money. Stocks pulling back a bit after this morning's hotter than expected inflation data. The Dow falling 234 points. The S &P and NASDAQ down about a half a percent. Shares of Warner Brothers Discovery jumping more than 15 percent. the company announcing a restructuring plan to segment its business into linear and streaming units in a move that could simplify future consolidation. This just weeks after CNBC's parent company, Comcast, announced it would spin out its cable networks. And cloud software provider ServiceTitan making its debut at the Nasdaq today. It traded as high as$105 but closed exactly where it opened,$101 a share.

23:51So well above its IPO price of$71. Leslie Picker's got all the details. Les. It's always weird when it does that closes exactly where it opens. But Service Titan, really seen as a bellwether for the tech IPO market, the software provider for plumbers and roofers and landscapers, etc., pricing above a boosted range, reportedly oversubscribed. And then, as you mentioned, Mal, popping in its debut today. Now, a lesser told story is that Service Titan didn't actually have much of a choice. It had to go public. When the company raised private capital back in 2022, it agreed to a provision called a compounding ratchet.

24:28This means that the company will need to issue more shares to make whole the investors, the venture investors, if an event such as an IPO or sale comes in below the valuation they paid in the prior round. And the compounding element, which is very, very unique, makes it more diluted for the company the longer it waits to go public. In this case, Service Titan pricing an IPO at$71 when it did today, or yesterday technically, trading today, was indeed lower than the latest private round. So the compounding ratchet was triggered. The overall dilution is pretty incremental, though, for Service Titan, just about 1 % according to estimates.

25:07Now, ironically, if the IPO were priced at the levels that it opened and closed at today,$101 per share, the compounding ratchet would be irrelevant. But this type of structure and the prospect of doing a down round has kept many prospective IPO candidates on the sidelines for a few years now. So we'll see if the moves today with Service Titan really changes the psychology, Mel. Karen's got a question. Yeah. Hi, Leslie. So on today's day one, were insiders selling? Who was selling? And when will lockups expire and they'll be able to sell? That's a good point. So the venture investors in the prior round included a bunch of late-stage folks that you normally expect to see.

25:52TPG was a participant in the prior round, and then they had a whole host of other venture kind of crossover investors in the prior rounds before that. Typically, these lockups tend to last about six months. I'm fairly positive this one is standard in terms of its lockup provisions, but it's a good point you mentioned because oftentimes when you do see those lockups expire, you see some more insider selling and that can put some pressure on the stocks. Those dates are always really, really important to keep an eye out for. All right. Leslie, thanks. Leslie Picker. This is one that really interested you guys on the 1230 conference call.

26:27Right. And we've been talking about as it relates to investment banks, like what the backlog looks for M &A, it looks for IPOs coming in 2025. If you talk to VCs, maybe they're wish casting because they need to recycle this cash. They need exits. But the bankers are super excited, too, because it's been so bad for the last couple of deals. So this is great. It was a down round, but it's fine. I guess the one issue I have is like, Leslie just mentioned this crossover investor. So these are large mutual funds. These are the natural buyers of these deals on IPOs. Well, they've been participating the whole time in these growth rounds.

26:58And so you start to wonder who are the incremental buyers? These companies have to start telling a really good story to retail investors to get their interest because a lot of the natural buyers don't really exist that much anymore. Yeah. No, I mean, I think it's expensive. It feels like this is great for them, great price. I actually saw them ringing the closing bell today as I was walking in. I'm sure it's super exciting. But when it really starts trading sort of freely, then I think it might be a different story. Really dependent on the housing market, obviously. So it's a housing play as well.

27:28You see restoration hardware. You get enthusiastic. Look at the home builders over the last week or so on the downside. So I think you tread lightly here. All right. Coming up, make crypto great again. President-elect Trump weighing in on the digital asset as Bitcoin hovers around$100 ,000. What he told our own Jim Cramer this morning and why our next guest says we are still early in this crypto rally. Fast Money's back in two. Missed a moment of fast? Catch us anytime on the go. Follow the Fast Money podcast. We're back right after this.

28:07We're going to do something great with crypto because we don't want China or anybody else, not just China, but others are embracing it and we want to be the head. That was President-elect Donald Trump speaking to Jim Cramer earlier today about putting the U.S. at the forefront of crypto. Bitcoin hovering around that$100 ,000 mark today. But our next guest says 2025 could be a big year for both Bitcoin and stable coins. He launched the first Bitcoin fund back in 2013. He's here on set with us. Pantera Capital founder and managing partner, Dan Moorhead. Dan, great to see you again. Great to see you.

28:37So this is a great year for crypto. Next year is going to be even better. And on what? Because a lot of this year feels like pull forward of the expectation that something will happen in the regulatory environment that will be very beneficial for Bitcoin and crypto in general. And we don't even know what that is. Yeah, I think that's what it was. The uncertainty. We're holding investors back. And I think over 2025, you're going to get much more clear regulations and that'll allow institutions to come into the space. And presently, most institutions really have almost zero exposure to blockchain.

29:09So once they start engaging in the space, it should do well. So this fund that you run is an institutional fund, correct? So what kind of conversations are you having now to segue into that time when institutions can actually allocate money? Oh, it's really changed since the election. Last summer when the markets were very low and we had very little interest. And since the election, so many people are trying to get, figure out what, how to get exposure to this space. When you hear a Microsoft, I think Michael Saylor just pitched the whole Bitcoin strategy of micro strategies to Microsoft. They passed.

29:44I think they might have passed in a prior lifetime, but they passed recently. Thoughts on that, that, you know, he is obviously pushing that, but a lot of people are sort of backing away. I mean, is there another company that has to come in to sort of galvanize what Michael's done? He's done a great job raising awareness, but probably most big corporations are not going to have Bitcoin on their balance sheet, just like they don't have yen or bonds or gold or whatever. But big institutions, insurance companies, pension plans, endowments, they're the ones that are going to come in and really push this market up.

30:18So what's preventing them right now, those big institutions? I mean, for some of them, I think there seems to be nothing preventing them. But what are some of the regulations that would be lifted that would allow that to happen? Well, it's been very unclear what is a security and what is not a security. The regulators in the U.S. are pursuing lawsuits against some of the bigger companies in this space. And so that gives institutions pause. If that gets cleared up, you could imagine institutions wanting to get access to a new asset class. This is very similar to commodities in the 80s or emerging markets in the 90s or mortgages in the 70s and 80s.

30:52It's just a new asset class. Most people don't have exposure to it yet. Dan, people keep talking about regulation or more clarity and the like here. How much of this move do you think has to do with, and Trump had been saying this on the campaign trail, the idea of some sort of Bitcoin reserve for the country. And, you know, is that a big part of this? Or obviously there's a lot of moving parts here. What are you most excited about what could come out of this other than regulation? I think that is actually a really important thing. When you're the reserve currency of the world, you don't have somebody else's currency to save in.

31:20So the United States doesn't have another currency. It stores$600 billion in gold, which is a staggering amount. It's equivalent to 11 million years of American worker wages. So that's kind of crazy. Go to digital gold. Bitcoin is much better. And so I do think it's totally rational. The U.S. already owns 1 % of the world's Bitcoins. Keep that. Increase that. So I do think it is actually a really good policy. There's a couple countries that already do own Bitcoin. It would be great for the U.S. to get out in the lead. How do you manage the portfolio in terms of, you know, you have outsized positions now just because of the run.

31:58And so where would you where are you trimming or where have you trimmed and what are some of the more undervalued cryptos out there? Yeah. So the fun bit about cryptos, we've been doing this for 11 years and Bitcoin's almost gone a little bit more than doubled this year. And so everyone's talking about isn't that wild it doubled. On average, it's done that for 11 years in a row. Right. So crypto going up double is not remarkable, actually. And so we're normally long because we think the markets are going to go up, you know, another huge amount, like another order of magnitude possibly. So we're typically long.

32:30We're always just looking at which other tokens are interesting. We have a big position in TAN, Telegram's token, Solana, Ondo. Those are some of ours. All right, Dan, great to see you. Thank you. Dan Moorhead of Pantera. So you can't, I mean, you know, people say Michael Sellers, you say what you want. He's very transparent in what he's doing. He's been this sort of, I don't know, Sherpa for the community. And he's done an extraordinary job. But, you know, Dan is spot on. I mean, there's going to be acceptance in the space and it's very hard to make a bearish argument right now. Yeah. You know, it's interesting when you think about Bitcoin.

33:03One of the knocks on it is that it doesn't do anything, doesn't create anything. Over the last 10 years, it's up 30 ,000 percent. You know what else is up 30 ,000 percent? NVIDIA, which has nearly double the market cap. And we know what's going on there. So it's really hard to compare these risk assets. It's like you have to think of it, I guess, the way Dan's talking about it, actually as a reserve currency or some sort of asymmetric sort of bet on something that we don't know what it could turn into. It could only go to zero, but on the flip side, it'd go to infinity. All right. Meantime, Terns Pharmaceuticals, among the many companies looking to get in on that world GLP-1 market, Phase 1 trial results published in September found the company's small molecule drug helped patients lose up to 5 % of their body weight in 28 days.

33:42But it's not all about weight loss. TURN's also planning to advance its leukemia drug in trial next year after giving positive data earlier this month. For more, let's bring in TURN CEO Amy Burrows. Amy, great to have you with us. Thank you so much for having me, Melissa. So the obesity drug is TURN 601. How does it fit into sort of the landscape here? We've got a lot of, you know, candidates out there, oral candidates, including ones by Novo as well as Eli Lilly. How does yours fit in and why do you think this could actually be best in class, which is what you said in the press release? Yeah, thanks, Melissa.

34:18So I know you know a lot about this space. We don't yet have an oral approved therapy. And we also have seen a lot of data from oral to say that we can see effective weight loss. We don't yet have that ideal drug where you see really good tolerability along with that weight loss, something that's very scalable from a manufacturing standpoint and available. I've also heard you talk about different patient segments in this market that different therapies could be appropriate for. So we at times don't think that there's going to be one winner in the oral GLP-1 race. Do you see your oral drug being more of a maintenance drug as opposed to the drug that you're on to lose that initial big portion of the body weight that needs to be lost?

35:01Yeah, you know, I think people are talking about that in general about orals, and I think it's really going to depend on the patient and the needs. Okay. Talk to us about the phase two. Is it on track to start in 2025? When can we expect a readout? Yeah, it's on track to start by early Q2, and you'll see a readout before the end of the year. Okay. You know, last week, we had some stunning news from an IPO in the space, BioAge, which halted its phase two. And I know this is not, it doesn't relate to you, but in terms of investors looking at sort of, you know, biotech companies developing drugs, early stages.

35:40They see the collapse and they think, why not just go to an Eli Lilly or a Novo Nordisk? Because you can see what happens when a drug is halted in a trial phase. What can you tell investors? I'm sorry. Can you clarify the question? What do you mean go to Lilly where you can see what happens? Well, Lilly's drugs are a little bit farther out in terms of development. They've got a drug that's already approved and on the market, whereas a smaller company is working on drug candidates. They are in clinical trials right now. And you can see what happens when a phase has to be halted because the endpoints are not met or for whatever reason, there's an adverse side effect.

36:16What can you tell investors about the risks? Because you see a collapse in a company that is also working on an obesity drug in phase two. And I'm sure people are getting cold feet. I have a lot of respect for my colleagues at BioAge, and it's very sad to see. I would say that, you know, earlier stage drug development is inherently riskier if you look at the statistics. But we also know that a lot of drugs, big classes like statins and others, the first to market is not necessarily the best or the winner. So I think there's a lot to be gained in investing in molecules that may be earlier in the pipeline but have the potential to be better.

36:55Amy, I think you have about$380 million of cash-to-cash equivalents. What kind of runway does that give you? We understand that this business is extraordinarily capital-intensive. It is capital-intensive. It's still very different if you're developing a gene therapy or a biologic. So that cash actually gets us into 2028 and into some pretty meaningful milestones, readouts on our leukemia drug, readouts on our obesity portfolio. All right, Amy, we're going to have to leave it there. Thanks for your time. We do appreciate it. Thank you so much, Melissa. Amy Burrows, and she had mentioned a chronic myeloid leukemia drug, which is going to start in phase two next year.

37:33So to your question, Guy, you need the money to fund all of these different trials. And they have it through 2028. I mean, the market cap is probably either side of half a billion dollars. So we'll tread lightly with this one. But it's one of these fascinating stories. You know, there was a company called Gleevec years ago. You might want to go back and look at it. very small micro cap company that then was subsequently bought for like 100x of what they went public at. So this could be one of those types of situations. Coming up, betting on the ponies, why horse racing could see a huge resurgence thanks to sports gambling and why the return of one famous trainer could help fuel the run down the stretch.

38:10More Fast Money in 2. Thank you.

38:41back and it was a triumphant return to Churchill Downs a couple weeks ago. Baffert won with a two-year-old horse, Barnes, which incidentally cost$3.2 million as a yearling. I sat down with a Hall of Fame trainer a couple days ago in Tucson near where he grew up and I asked him about starting this new chapter. We went through some challenging times and we got through it and it's so nice to have all that in the rearview mirror behind me and i can focus on what's going on ahead and it's it's going to be it's going to be i'm having fun i'm having fun again do you think there's any sustained damage to the baffert brand i think people in horse racing they understand what went on and it's uh it's one of those things where you just got to put it behind you Baffert was speaking at the University of Arizona Racing Symposium.

39:37It's his alma mater. And the persistent topic that I heard there, where is this sport going? There's been decades of declining horses, owners, trainers. And Baffert thinks there needs to be more high-profile events like the Kentucky Derby. It's getting bigger, the handle. There are many more people show up. And why? Because it's a it's an Instagram moment for everybody. Everybody goes. They're taking their same. I'm here at the biggest party. It's a bucket list race and it's getting bigger and bigger. Baffert's not the only one focused on the next opportunities. I talked with fellow trainer Todd Pletcher, Donna Barton Brothers, the NBC racing analyst who talked about the importance of sports books because gambling funds the purses.

40:22and widespread sports betting is bringing in all these new fans. And then you guys know Danny Moses, a big short fame and a friend to Fast Money. He owns horses with other investors in Starlight Racing, and he and founder Jack Wolf were out there in Tucson. And I heard a lot of talk about gate races to host four-year-old horses, expand their careers. And this is where investors would own the racing positions themselves or the slots. They can buy it. They can sell it. They can trade them. and so it makes the actual race sort of more of a wagering game, if you would. Like, where are you going to get your return on investment for these positions?

41:01There's a lot of innovation that is possible in horse racing, but it's not quite there yet. The next big thing, I think, is what everybody's looking at to see whether they can make a resurgence. Is the audience older? I mean, do we need to bring younger people to watch? And part of it, to the point, is, you know, you've got the Kentucky Derby. Everybody loves it. You have the Breeders' Cup and then the other Triple Crown races. But Baffert was like, look, it's kind of like baseball, right? You've got all of these games. You've got to fill those stands. How do you do it? You need superstars. So is it the horses that are superstars?

41:35Or the jockeys? No. The owners? The jockeys. And maybe the owners and maybe it's the trainers. But if you can get one more year of racing career for the horses, the horses themselves could be the stars. Well, Contessa's a star. And check out Churchill Downs. Look at the stock over the last decade. Still cheap despite the run. Contessa, it's always great to see you. Thank you, Melissa. What an interview. Contessa Brewer, up next, Final Trades.

42:13Final Trade time. Karen. Yes, a shout out to my brother, Mark Feinerman. Happy birthday. And I still like the IWM. Danny. Yeah, I kind of like this XLV. It's had four-year support at 140. Interesting guy. Special final trade here. Jack Duffy in a hospital room in Northwestern. Your kid brother is really proud of you. I know you're proud of him as well. So feel better on behalf of all your friends here at CNBC's Fast Money. May we say who the kid brother is? That would be Terry Duffy of CNBC. One and only. Yeah. All right. Thanks for watching Fast Money. Mad Money with Jim Kramer starts right now.

43:18information the Fast Money participants consider reliable, but neither CNBC nor its affiliates and or subsidiaries warrant its completeness or accuracy, and it should not be relied upon as such. To view the full Fast Money disclaimer, please visit cnbc.com forward slash Fast Money disclaimer.

From the publisher

Another record close for Apple as the tech titan’s rally continues. The driving factors behind those gains, as the company’s market cap nears the $4 trillion mark. Plus Make Crypto Great Again? President-Elect Donald Trump weighing in on the crypto space as Bitcoin hovers near $100K. The future of crypto under Trump, and why the founder of the world’s first institutional Bitcoin fund says the rally is just getting started.

Fast Money Disclaimer


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

More from CNBC's "Fast Money"

All 872 episodes
Apple’s Rally Keeps Running… And Trump’s Crypto Plans 12/12/24CNBC's "Fast Money" · 44 min
Listen in VO